A Clinical Study Evaluating the Efficacy and Safety of HRS-7249 in Treating Patients With Hyperlipidemia

Who May Qualify: 1. Able and willing to provide a written willing to sign a consent form. 2. Age ≥ 18 years old and \< 80 years old. 3. Male or female. Who Should NOT Join This Trial: 1. Acute pancreatitis within 3 months or within 4 weeks or planned for plasma exchange treatment. 2. Malignant tumors within 5 years. 3. Severe cardiovascular or cerebrovascular diseases. 4. Severe trauma or surgery within 6 months or severe infection within 3 months. 5. Previous diagnosed diseases affecting lipid levels. 6. Patients with unstable or severe diseases assessed as at risk by the investigator. 7. Uncontrolled hypertension. 8. Weight loss within 2 months or planned surgery causing unstable weight. 9. Uncontrolled diabetes. 10. Combined hyperthyroidism or hypothyroidism. 11. History of drug or alcohol abuse. 12. Significantly abnormal liver or kidney function. 13. Significantly abnormal blood routine. 14. Significantly abnormal thyroid function. 15. Participated in clinical research within 3 months. 16. Pregnant or lactating women, or refusing contraception. Always talk to your doctor about whether this trial is right for you.